The Stockholm Stock Exchange posted gains on Monday. Epiroc's earnings report was well received, providing support to the industrial sector. Mining companies such as Lundin Mining and Boliden also performed strongly, buoyed by rising precious metal prices. Later this week, several major earnings reports are due, along with interest rate announcements from the Federal Reserve and the Riksbank.

At the close, the OMXS30 index was up 0.35 percent at 3,024.15. Shares worth approximately SEK 24.0 billion were traded on the Stockholm Stock Exchange.

The best performance among the market's larger industrial sectors came from raw materials, which rose by 1.4 percent. On the other hand, energy was at the bottom, down 0.8 percent.

Among the leading stocks included in the OMXS30 index, Epiroc A climbed 7.5 percent while Boliden gained 4.3 percent. The worst performer was EQT, down 3.6 percent, while Saab B fell 2.5 percent.

Mining and rock excavation technology company Epiroc's adjusted operating profit and revenue for the fourth quarter were slightly below expectations. On the positive side, order intake met consensus and recorded an organic increase of 11 percent. Several industry peers followed Epiroc's upward trend, with Sandvik up 1.8 percent and ABB rising 1.6 percent.

Contract manufacturer Note reported higher earnings in the fourth quarter of 2025 compared to the same quarter last year. Revenue declined a few percent, coming in at the lower end of the company's guidance. The board proposes to scrap the dividend, compared to SEK 7 per share last year. The order book at year-end was 11 percent higher than at the same time the previous year for comparable units. The stock closed 1.9 percent higher after a volatile session.

Industrial communications company Ependion saw its operating profit decrease in the fourth quarter compared to the same period last year. Revenue was essentially unchanged, while order intake increased and the dividend was raised. The share dropped 2.0 percent.

Research company Bioarctic's partner Eisai received priority review from the U.S. Food and Drug Administration (FDA) for a supplemental application regarding Leqembi Iqlik as a subcutaneous autoinjector for weekly initiation treatment. A decision from the FDA is expected by May 24. The stock rose 3.3 percent.

Engineering group Beijer Alma's CEO and Group President Oscar Fredell is stepping down immediately for personal reasons, after less than three months in the role. The share fell 3.3 percent.

Medical technology company Episurf Medical is acquiring a property portfolio from Klarabo valued at SEK 897 million. Episurf surged 23 percent while Klarabo dropped 7.6 percent.

Handelsbanken upgraded its recommendation for telecom supplier Ericsson to buy from hold. The share rose 0.3 percent.

Industrial trading company Bufab climbed 2.7 percent after a buy recommendation from Dagens industri.

Credit management company Intrum gained 4.9 percent after ABG Sundal Collier raised its recommendation to buy from hold. ABG did the opposite for property developer JM, downgrading its recommendation to hold from buy. JM fell 2.2 percent.

Installation company Bravida initially rose after Handelsbanken began coverage with a buy recommendation, but lost ground and closed 0.7 percent lower.

Real estate platform Hemnet fell 9.4 percent after BNP Paribas downgraded its recommendation to underperform from neutral.